Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec 3:11:1528452.
doi: 10.3389/fmed.2024.1528452. eCollection 2024.

Editorial: New insights into the role of imaging in large vessel vasculitis

Juan Molina-Collada  1 , Philipp Bosch  2 , Eugenio de Miguel  3 , Wolfgang A Schmidt  4 , Christian Dejaco  2   5
Affiliations
Editorial

Editorial: New insights into the role of imaging in large vessel vasculitis

Juan Molina-Collada et al. Front Med (Lausanne). .
No abstract available

Keywords: MRI; PET-CT; Takayasu arteritis; giant cell arteritis; imaging; large vessel vasculitis; polymyalgia rheumatica; ultrasound.

PubMed Disclaimer

Conflict of interest statement

JM-C has received consultancy/speaker's fees from AbbVie, Lilly, Janssen, Novartis, Pfizer, UCB, MSD, and BMS; trial participation as principal investigator for Novartis. None of these fees were related to the present manuscript. PB has received speaker and add board fees from Janssen and AbbVie, speaker fees from Lilly and projects grants from Pfizer. EM speakers bureau: AbbVie, Novartis, Pfizer, MSD, BMS, UCB, Roche, Grünenthal, Janssen, and Sanofi; paid instructor for: Janssen, Novartis, and Roche; consultant of: AbbVie, Novartis, Pfizer, and Galapagos; Grant/research support from: AbbVie, Novartis, and Pfizer. WS has received speaker honoraria from AbbVie, Amgen, Bristol Myers Squibb, Chugai, GlaxoSmithKline, Johnson & Johnson, Medac, Novartis, Roche, and UCB; advisory board honoraria from AbbVie, Amgen, Boehringer Ingelheim, Fresenius Kabi, GlaxoSmithKline, Novartis, and Sanofi; trial participation as principal investigator for AbbVie, GlaxoSmithKline, Novartis, and Sanofi. CD has received consulting/speaker's fees from Abbvie, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Galapagos, Sparrow, Boehringer, and Sanofi; grant support from AbbVie and Novartis, all unrelated to this manuscript. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic New insights into the role of imaging in large vessel vasculitis

Similar articles

See all similar articles

References

    1. Bosch P, Bond M, Dejaco C, Ponte C, Mackie SL, Falzon L, et al. . Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open. (2023) 9:e003379. 10.1136/rmdopen-2023-003379 - DOI - PMC - PubMed
    1. Schmidt WA, Kraft HE, Völker L, Vorpahl K, Gromnica-Ihle EJ. Colour Doppler sonography to diagnose temporal arteritis. Lancet. (1995) 345:866. 10.1016/S0140-6736(95)93005-1 - DOI - PubMed
    1. Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, et al. . EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. (2023) 2023:ard-2023-224543. 10.1136/annrheumdis-2023-eular.7009 - DOI - PubMed
    1. Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. . 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. (2022) 81:1647–53. 10.1136/ard-2022-223480 - DOI - PubMed
    1. Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, et al. . 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. (2022) 81:1654–60. 10.1136/ard-2022-223482 - DOI - PubMed

Publication types

LinkOut - more resources